S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.12%) $83.24
Gas
(0.46%) $1.760
Gold
(-0.29%) $2 406.70
Silver
(-0.34%) $28.75
Platinum
(-0.05%) $943.30
USD/EUR
(-0.12%) $0.938
USD/NOK
(-0.28%) $11.01
USD/GBP
(0.52%) $0.808
USD/RUB
(-0.74%) $93.20

Aktualne aktualizacje dla Response Genetics, Inc [RGDXQ]

Giełda: OTC Sektor: Healthcare Branża: Diagnostics & Research
Ostatnio aktualizowano15 geg. 2023 @ 19:32

0.00% $ 0.0000010

Live Chart Being Loaded With Signals

Commentary (15 geg. 2023 @ 19:32):

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally...

Stats
Dzisiejszy wolumen 77 000.00
Średni wolumen 0.00
Kapitalizacja rynkowa 116.00
EPS $-0.108 ( 2015-03-31 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)

Wolumen Korelacja

Długi: -0.48 (neutral)
Krótki: 0.00 (neutral)
Signal:(51.968) Neutral

Response Genetics, Inc Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Response Genetics, Inc Korelacja - Waluta/Towar

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Response Genetics, Inc Finanse

Annual 2015
Przychody: $18.04M
Zysk brutto: $3.94M (21.85 %)
EPS: $-0.521
Q1 2015
Przychody: $3.79M
Zysk brutto: $1.48M (38.94 %)
EPS: $-0.100
Q4 2014
Przychody: $4.08M
Zysk brutto: $1.63M (40.07 %)
EPS: $-0.0900
Q3 2014
Przychody: $4.46M
Zysk brutto: $1.92M (43.05 %)
EPS: $-0.0900

Financial Reports:

No articles found.

Response Genetics, Inc

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej